Bhinneka News Online: Reuters Health Report: May 1, 2017

Monday, 1 May 2017

Reuters Health Report: May 1, 2017

Click to View in Browser

Monday, May 1, 2017

No vote on healthcare bill this week in U.S. House

WASHINGTON (Reuters) - U.S. House leaders have decided against holding a vote on a reworked healthcare system overhaul this week after failing to find the necessary support, congressional aides said on Thursday.

Home blood pressure monitors may not be accurate enough

(Reuters Health) – Even as doctors are increasingly relying on home blood pressure monitoring to manage patients with hypertension, many of the devices are too inaccurate to be useful, according to a small study.

With Obamacare in doubt, California asks insurers to double up on rate filings

NEW YORK (Reuters) - Health insurers seeking regulatory approval for 2018 individual insurance plans can file two sets of premium rates as a way to deal with market uncertainty created by Republicans' promise to repeal and replace Obamacare, a California state insurance regulator said on Friday.

U.S. FDA approves Takeda's lung cancer drug as second-line treatment

(Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Friday that the U.S. Food and Drug Administration approved its lung cancer drug, almost three months after the company acquired the drug's developer, Ariad Pharmaceuticals Inc.

Malaria, wiped out in U.S., still plagues American travelers

(Reuters Health) - U.S. public health officials declared victory over malaria in 1951, but the mosquito-borne disease continues to infect and kill American travelers, a new study shows.

U.S. FDA approves Novartis' leukemia treatment

(Reuters) - The U.S. Food and Drug Administration approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other blood disorders, the agency said on Friday.

Mexican Congress approves use of medical marijuana

MEXICO CITY (Reuters) - Mexico's Lower House of Congress passed a bill on Friday to legalize the use of marijuana and cannabis for medical and scientific needs, a step closer to outright legalization in a country long scarred by warring drug cartels.

FDA approves Radius Health's osteoporosis drug Tymlos

(Reuters) - The U.S. Food and Drug Administration on Friday approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies.

Is active surveillance safe for men with family history of prostate cancer?

(Reuters Health) - Having a family history of prostate cancer doesn't make it more risky for men with a new diagnosis of the disease to initially hold off on active treatment in favor of monitoring with periodic lab tests, a research review suggests.

Rethink emphasis on lowering saturated fat to save hearts: docs

(Reuters Health) - Instead of eating less saturated fat and worrying about so-called bad cholesterol, a group of doctors suggests an alternative approach for preventing heart disease.